10-Q · May 4, 2026
This 10-Q does not provide operating financial statements or quantitative information on revenue, margins, EPS, cash flow, or segments, so period-over-period performance cannot be assessed. The filing instead emphasizes…
Earnings analysis · 10-Q
Filed August 14, 2026 · Our reading of the company's report
The latest report
Enhanced Group generated its first meaningful revenue in Q2 2026, reporting $17.7 million versus $0 in the prior-year quarter, but a $61.9 million net loss and approximately negative 349.8% operating margin reflect…
Enhanced Group generated its first meaningful revenue in Q2 2026, reporting $17.7 million versus $0 in the prior-year quarter, but a $61.9 million net loss and approximately negative 349.8% operating margin reflect substantial launch, transaction and infrastructure costs. Cash was $19.6 million at quarter-end, operating cash flow was negative $44.0 million for the first six months, and management disclosed substantial doubt about the Company’s ability to continue as a going concern within one year. Management expects inaugural Games costs and transaction expenses to decline, but the Company remains dependent on the approximately $13.3 million Tranche 3 financing and additional capital thereafter.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Q2 revenue was $17.7 million versus $0 in Q2 2025, representing the Company’s first meaningful revenue and an increase of $17.7 million year over year. Revenue was primarily generated from Enhanced Games sponsorship arrangements.
Management signed approximately $32 million of aggregate sponsorship deal value to date, including arrangements with Zoop, Rezolve and Rumble. Approximately $10 million of contracted Zoop value remained unrecognized as of June 30, 2026 pending collectability and performance obligations.
The Company launched the Enhanced Games in May 2026 and the first Enhanced Breakers event on July 11, 2026. Management expects the Breakers format to operate on a substantially smaller cost base than the inaugural event.
The Company held $19.6 million of cash and cash equivalents at June 30, 2026 and had no borrowings outstanding after repaying the $11.75 million Working Capital Note. The Tranche 3 Closing is expected to provide approximately $13.3 million of additional gross proceeds.
Live Enhanced expanded beyond its initial offering to include OTC supplements, hormone and longevity protocols, peptide-based protocols, GLP-1 and GLP-1/GIP weight-management protocols, athlete-inspired bundles and apparel as of July 2026.
Management expects Games, athletes and event costs of $52.0 million in Q2 2026 to decline substantially because the inaugural event included one-time venue, broadcast, construction and clinical-program investments. Transaction expenses of $10.9 million in Q2 are also described as non-recurring.
Management concluded that substantial doubt exists regarding going-concern status within one year of issuance. Cash was $19.6 million at June 30, 2026, while the Company reported a six-month net loss of $78.4 million and expects to require capital beyond the approximately $13.3 million expected from the Tranche 3 Closing.
Operating cash flow was negative $44.0 million for the six months ended June 30, 2026, compared with negative $7.5 million in the prior-year period. Accounts payable and accrued expenses reached $40.1 million, reflecting significant Games and transaction-related obligations.
Q2 operating expenses were $79.6 million against $17.7 million of revenue, producing a loss from operations of $61.9 million and an operating margin of approximately negative 349.8%. Games, athletes and event costs alone were $52.0 million.
Disclosure controls were not effective as of June 30, 2026 because of material weaknesses involving entity-level controls and the financial close process, third-party valuation reports and user-access IT general controls. Management expects remediation efforts to continue through fiscal 2026 and into 2027.
The Company issued or agreed to issue 12,853,468 PIPE Warrants, and the Tranche 3 Closing would involve 3,406,170 additional shares and accompanying warrants. Future warrant exercises, equity offerings and anti-dilution adjustments could materially dilute existing shareholders.
TRT is currently the only controlled substance offered on Live Enhanced, and the current telehealth prescribing extension is scheduled to remain in effect through December 31, 2026. More restrictive permanent rules or expiration without final regulations could require changes to provider arrangements or suspension of TRT offerings.
No explicit numeric revenue or EPS guidance was provided. Management expects operating cash outflows to decline during the remainder of 2026, expects Games costs to decline substantially in future periods, expects approximately $13.3 million of gross proceeds from the Tranche 3 Closing, and states that additional capital will be required.
This 10-Q does not provide operating financial statements or quantitative information on revenue, margins, EPS, cash flow, or segments, so period-over-period performance cannot be assessed. The filing instead emphasizes…
A Paradise Acquisition Corp. remains a pre-operating SPAC with no revenue, operating business, or meaningful multi-year operating history. Its 2025 results improved to $2,568,594 of net income, but that result was…
The extracted filing is primarily a post-IPO SPAC disclosure and does not include an income statement, balance sheet, cash-flow statement, operating segments, or quantitative guidance; therefore, revenue, margins, EPS,…
The extracted filing does not include the income statement, balance sheet, cash-flow statement, MD&A, or segment disclosures, so revenue, margins, EPS, cash flow and operating trends cannot be assessed. Management…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.